We are live on ! Find out more
XNCR icon

Xencor

195 hedge funds and large institutions have $1.36B invested in Xencor in 2023 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 76 increasing their positions, 57 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

490% more call options, than puts

Call options by funds: $59K | Put options by funds: $10K

106% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 17

33% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 57

10% more funds holding

Funds holding: 178195 (+17)

7% more capital invested

Capital invested by funds: $1.27B → $1.36B (+$88.3M)

1.09% more ownership

Funds ownership: 104.34%105.43% (+1.1%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
195
Holders Change
+17
Holders Change %
+9.55%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
35
Increased
76
Reduced
57
Closed
17
Calls
$59K
Puts
$10K
Net Calls
+$49K
Net Calls Change
+$103K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$240M +$16.6M +873,507 +8%
Primecap Management
2
Primecap Management
California
$189M +$13.6M +717,401 +9%
Vanguard Group
3
Vanguard Group
Pennsylvania
$144M +$2.2M +115,886 +2%
EC
4
EcoR1 Capital
California
$112M
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$74M +$5.69M +298,841 +9%
State Street
6
State Street
Massachusetts
$70.6M +$6.63M +348,255 +12%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$54.4M -$16.5M -868,990 -25%
AC
8
Armistice Capital
New York
$31.8M +$419K +22,000 +1%
Morgan Stanley
9
Morgan Stanley
New York
$31.6M +$17.9M +938,474 +170%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$28.7M -$46.2M -2,426,996 -64%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$27.9M +$1.05M +54,991 +4%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$27.2M -$3.28M -172,270 -12%
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$21M -$9.86M -518,308 -34%
JJ
14
Johnson & Johnson
New Jersey
$15.9M
Northern Trust
15
Northern Trust
Illinois
$15.3M +$849K +44,625 +7%
CS
16
Candriam SCA
Luxembourg
$15M +$1.05M +55,000 +8%
Charles Schwab
17
Charles Schwab
California
$11.1M +$614K +32,251 +7%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$10.8M +$437K +22,958 +5%
JP Morgan Chase
19
JP Morgan Chase
New York
$10.6M -$65K -3,417 -0.7%
Goldman Sachs
20
Goldman Sachs
New York
$9.3M +$4.84M +254,537 +139%
Two Sigma Investments
21
Two Sigma Investments
New York
$8.4M +$3.24M +170,051 +75%
Millennium Management
22
Millennium Management
New York
$7.44M -$7.18M -377,254 -52%
Principal Financial Group
23
Principal Financial Group
Iowa
$7.26M -$78.1K -4,107 -1%
EAM
24
Erste Asset Management
Austria
$7.1M +$2.09M +110,000 +49%
Norges Bank
25
Norges Bank
Norway
$6.91M -$516K -27,100 -8%

XNCR Hedge Fund Activity: Q4 2023 in Review

195 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Xencor (XNCR) for Q4 2023, worth a combined $1.36B — up 6.9% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new XNCR positions and 17 closed out — a net gain of 18 holders — while 76 added to existing stakes and 57 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $17.9M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $46.2M.

  • 195 institutional investors held Xencor (XNCR) as of Q4 2023, up from 178 in Q3 2023.
  • Funds reported $1.36B of Xencor stock for Q4 2023, up 6.9% quarter-over-quarter.
  • 35 funds opened new Xencor positions in Q4 2023 and 17 closed out, a net change of +18 holders.
  • The largest Xencor buyer in Q4 2023 was Morgan Stanley, an estimated $17.9M added.
  • The largest Xencor seller in Q4 2023 was T. Rowe Price Investment Management, an estimated $46.2M sold.

Based on aggregated 13F filings for Q4 2023.